Newsletter Subject

VEGFs and Receptors: Key Mediators in Vascular and Nervous Systems

From

newscientist.com

Email Address

NewScientist@e.newscientist.com

Sent On

Mon, Sep 13, 2021 04:29 PM

Email Preheader Text

Every now and then, New Scientist helps a carefully selected commercial partner speak to our audienc

Every now and then, New Scientist helps a carefully selected commercial partner speak to our audience. Their support helps us produce the high quality journalism we bring you every week. We hope you find today's message relevant and useful. [VEGFs and Receptors]( Vascular endothelial growth factors (VEGFs) are a family of secreted polypeptides with mitogenic and angiogenic activities. The importance of VEGFs and receptors in angiogenesis, tumorigenesis, and neuroprotection makes them attractive targets for drug development. The VEGF family members [VEGF-A]( [VEGF-B]( [VEGF-C]( [VEGF-D]( VEGF-E, VEGF-F, and [PlGF]( bind in specific patterns to three related receptor protein tyrosine kinases, [VEGFR1/FLT1]( [VEGFR2/KDR]( and [VEGFR3/FLT4]( and two non-tyrosine kinase transmembrane proteins, neuropilin-1 ( [NRP1]( and neuropilin-2 ([NRP2](. The ligand-receptor binding induces the formation of homo- and heteromeric receptor complexes and activates downstream signaling. In addition to VEGF signaling, neuropilins also act as co-receptors to numerous other signaling pathways, including those triggered by Epidermal Growth Factor ( [EGF]( Fibroblast Growth Factor ([FGF]( Hepatocyte Growth Factor ( [HGF]( Insulin-like Growth Factor ( [IGF]( Platelet-Derived Growth Factor ([PDGF]( and Transforming Growth Factor beta ( [TGFβ](. [Register Now]( VEGF Family Ligands and Receptors Sino Biological has over 65 recombinant VEGF & receptor proteins covering all VEGF family members and several isoforms of VEGF. A vast majority of these recombinant proteins were expressed in eukaryotic cells (human cells or insect cells), which ensures proper modification and higher activity of proteins. • High Activity Human / Cynomolgus VEGF165 (Cat#: [11066-HNAH]( Human KDR (Cat#: [10012-H08H]( Cell proliferation assay using human umbilical vein endothelial cells (HUVEC) Inhibit the VEGF-dependent proliferation of human umbilical vein endothelial cells (HUVEC) • Recommended Recombinant VEGF & Receptor Proteins Cat# Molecule Species Activity Tag [10136-H02H]( VEGFR1/FLT-1 Human Active hFc [10136-H08H]( VEGFR1/FLT-1 Human Active His [10136-H08H1]( VEGFR1/FLT-1 Human Active His [10806-H02H]( VEGFR3/FLT4 (ECD) Human Active hFc [50584-M02H]( VEGFR3/FLT-4 Mouse Active hFc [10012-H02H]( VEGFR2/KDR Human Active hFc [10012-H02H1]( VEGFR2/KDR (Domain 1&2&3) Human Active hFc [10012-H02H1-B]( VEGFR2/KDR (Domain 1&2&3) Human hFc [10012-H02H2]( VEGFR2/KDR (Domain 2&3) Human Active hFc [10012-H08H2]( VEGFR2/KDR (Domain 2&3) Human His [10012-H20B1]( VEGFR2/KDR Human Active GST & His [50998-M08H-B]( VEGFR2/KDR Mouse Active His [80113-R02H]( VEGFR2/KDR Rat Active hFc [80113-R08H]( VEGFR2/KDR Rat His [90907-C08H]( VEGFR2/KDR Cynomolgus His [10011-H08H]( NRP1 Human Active His [10695-H02H]( NRP2 Human Active hFc [11066-HNAB-B]( VEGF165 Human, Cynomolgus Native [11066-HNAH]( VEGF165 Human, Cynomolgus Active Native [63004-ZNAB]( VEGF165 Danio rerio (zebrafish) Active Native [70004-DNAH]( VEGF164 Canine Active Native [80006-RNAB]( VEGF164 Rat Active Native [10544-H01H]( VEGFB Human Active hFc [80103-R01H]( VEGFC (aa 108-223) Mouse, Rat Active hFc [80103-R08H]( VEGFC (aa 108-223) Mouse, Rat Active His [50157-M01H]( VEGFD Mouse Active hFc [50157-M08H]( VEGFD Mouse Active His [80104-R01H]( VEGFD Rat Active hFc [10274-H05H]( PIGF Human Active mFc • More Recombinant VEGF & Receptor Proteins [VEGFA]( [VEGFB]( [VEGFC]( [VEGFD]( [PIGF]( [VEGFR1/FLT-1]( [VEGFR2/KDR]( [VEGFR3/FLT-4]( [NRP1]( [NRP2]( VEGF/VEGFR Antibodies Sino Biological has over 100 antibodies against VEGF & receptor proteins with validated activities in various applications, including western blotting, ELISA, immunohistochemistry, immunofluorescence, flow cytometry, and neutralization. ELISA kits and ELISA pair sets are also available. • Antibody List of CSFs and CSFR [Anti-VEGFA]( [Anti-VEGFC]( [Anti-VEGFD]( [Anti-PIGF]( [Anti-VEGFR1/FLT-1]( [Anti-VEGFR2/KDR]( [Anti-VEGFR3/FLT-4]( [Anti-NRP1]( [Anti-NRP2]( [Sino Biological]( Sino Biological US Inc. [Tel:] +1-215-583-7898 [Order:]order_us@sinobiologicalus.com [CRO Service:]cro_us@sinobiologicalus.com [Address] 1400 Liberty Ridge Drive, Suite 101, Wayne, PA 19087 * This email has been sent to {EMAIL} * [Unsubscribe]( from further emails relating to selected third party partners from New Scientist. * Read our [privacy policy]( Disclaimer This message is intended only for the use of the person(s) ("Intended Recipient") to whom it is addressed. It may contain information, which is privileged and confidential. Accordingly any dissemination, distribution, copying or other use of this message or any of its content by any person other than the Intended Recipient may constitute a breach of civil or criminal law and is strictly prohibited. If you are not the Intended Recipient, please contact the sender as soon as possible. We and our third party service providers may use cookies and other web technologies in conjunction with this email. These technologies are used to understand activity with this email and on certain portions of our website. This enables us to improve our site, your experience on our site, and the offerings that we may provide to you. If you do not want these technologies placed on your device, please opt-out of receiving emails from us. New Scientist Ltd Registered Office: 25 Bedford Street, London, WC2E 9ES Registered in England under Company No. 10644366 Australian Office: Suite 3, Level 11, 100 Walker Street, North Sydney NSW 2060 Registered in Australia under ABN 22 621 413 170

Marketing emails from newscientist.com

View More
Sent On

30/08/2024

Sent On

30/08/2024

Sent On

29/07/2024

Sent On

01/07/2024

Sent On

10/06/2024

Sent On

20/05/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.